Cecilia Frej (Former)
1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Reduced Apolipoprotein M and Adverse Outcomes across the Spectrum of Human Heart Failure
(
- Contribution to journal › Article
- 2019
-
Mark
Plasma Apolipoprotein M and Sphingosine-1-Phosphate Levels are Inversely Associated with Mortality in African Americans with Type 2 Diabetes Mellitus
(
- Contribution to journal › Article
- 2018
-
Mark
High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate
(
- Contribution to journal › Article
- 2017
-
Mark
A Shift in ApoM/S1P between HDL-Particles in Women with Type 1 Diabetes Mellitus Is Associated with Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex
(
- Contribution to journal › Article
-
Mark
High-Density Lipoprotein–Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1
(
- Contribution to journal › Article
- 2016
-
Mark
The ApoM/S1P-complex: its role in vascular inflammatory disease and interaction with S1P-receptors
2016)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons
(
- Contribution to journal › Article
- 2015
-
Mark
Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation.
(
- Contribution to journal › Article